Soiken
- Company typePublic
- Founded1994
- HeadquartersToyonaka, Japan
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
Soiken firmographics
Firmographics- Name
- Soiken
- Legal name
- 株式会社総医研ホールディングス
- Website
- https://soiken.com
- Company type
- Public
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Soiken industry classification
Industry- Product category
- Biomarker-based Healthcare & Contract Research
- NAICS
- Testing Laboratories and Services (541380), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
- akta.pro secondary industry
- Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs (AFALAAAO)
Keywords
Where Soiken is headquartered
LocationHeadquarters
- HQ city
- Toyonaka
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
Soiken business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- Evaluation Testing Services (評価試験事業): Commissioned clinical evaluation testing services for foods and other products based on biomarker technology, serving food and pharmaceutical companies developing foods with functional claims (Tokuho, functional display foods).
- Biomarker Development (バイオマーカー開発事業): Technology licensing, co-development, and provision of biomarker technology to external companies and partners.
- Health Supplement Business (健康補助食品事業): Sales of health supplements centered on the anti-fatigue product Imidapeptide (drinks and soft capsules), sold via direct e-commerce and wholesale to drugstores. The business will be strengthened as 'Self-medication Support Mail-order Business'.
- Cosmetics Business (化妆品事業): Development and sales of high-functionality cosmetics using placental extracts. BB Laboratories brand sold domestically and internationally, with a planned wind-down of the subsidiary BB Laboratories by March 2026; domestic operations transfer to Japan Preventive Medicine.
- Healthcare Support Services (ヘルスケアサポート事業): Services provided to health insurance associations including health checkup promotion support, specific health guidance, diabetes prevention services, and various health management support services leveraging the company's medical institution network.
- Functional Ingredients Development (功能性素材開発事業): Development, sales, and technology licensing of functional ingredients centered on lactoferrin, conducted by NRL Pharma.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Soiken product offering
Product offeringCore offering
Soiken Holdings is a Japanese healthcare holding company that commercializes university-derived biomarker and biological evaluation technologies. It sells contracted clinical evaluation testing for foods and pharmaceuticals, develops and licenses biomarker technologies (ATMT for mental fatigue/dementia, HHV-6/HHV-7 fatigue quantification), produces the Imidapeptide-based anti-fatigue health supplement line, and delivers preventive healthcare support services to health insurance associations.
Product overview
Soiken Holdings Inc. operates as a healthcare group centered on biomarker technology-based 'evidence' development across multiple business domains. The company functions as a pure holding company (持株会社) with four primary subsidiaries: Sōiken Institute (evaluation testing, biomarker development, healthcare support), Japan Preventive Medicine (health supplements, lactoferrin, cosmetics), NRL Pharma (functional ingredients), and Virus Medical Science Research Institute (fatigue quantification, gene therapy). The flagship product is Imidapeptide anti-fatigue supplements, supported by proprietary biomarker and biological evaluation systems including the ATMT diagnostic technology. The group provides B2B contract research services, B2C consumer health products, and healthcare support services to insurance associations.
Differentiator
Problem solved
Functional benefit
Brands
- イミダペプチド: 疲劳项目中开发的抗疲劳成分（イミダゾールジペプチド），以饮料及软胶囊形式销售的主力健康保健食品。
Products and services
- Imidapeptide (イミダペプチド) Anti-Fatigue Supplements Beverages and soft capsules containing carnosine and anserine (imidazole dipeptides) developed from the company's fatigue project; sold to individual consumers seeking evidence-based anti-fatigue solutions.
- Evaluation Testing Services (評価試験事業) Commissioned clinical evaluation testing for foods, pharmaceuticals and health products based on biomarker technology; supports Foods with Functional Claims (Tokuho) and other regulatory submissions for food and pharmaceutical clients.
- Biomarker Technology Licensing (バイオマーカー開発事業) Technology licensing and co-development of proprietary biomarker platforms with external food and pharmaceutical companies; includes out-licensing of the ATMT method.
- Healthcare Support Services (ヘルスケアサポート事業) Preventive care services for health insurance associations including specific health examination promotion, specific health guidance, diabetes prevention programs, and health management support leveraging the company's medical institution network.
- Placental Extract Cosmetics (BB Laboratories) High-functionality cosmetics using placental extracts sold under the BB Laboratories brand domestically in Japan and internationally in China and other Asian markets.
- Functional Ingredients Development (NRL Pharma - Lactoferrin) Development, sales and technology licensing of functional ingredients centered on lactoferrin, conducted by subsidiary NRL Pharma; ingredients are used in health supplements and cosmeceuticals.
- Imidapeptide Official Online Store (イミダペプチド公式通販) Direct-to-consumer e-commerce platform for Imidapeptide products, including subscription/regular purchase with Imeda Points loyalty rewards tied to shareholder benefit program.
Quantifiable outcome
- Fatigue project identified 6 effective anti-fatigue components out of 23 candidates tested
- +2 more outcomes
Companies that use Soiken
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Soiken technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Soiken partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered moderate, core and minor.
- Global Beauty Technology株式会社 (高浪控股股份有限公司 group)moderatePartnership between Japan Preventive Medicine and Global Beauty Technology (a subsidiary of Gaolang Holdings Limited) for manufacturing and purchasing of health supplements for the China and Asian markets. Includes a basic manufacturing and purchasing contract for joint product development and distribution expansion in Asian markets.
- Hangzhou Golong Holding Co., Ltd.coreCapital and business partnership formed in February 2019 for cosmetics sales and health supplement distribution in the Chinese market. Golong Holding is the largest shareholder at 17.68% ownership (as of June 2025). The partnership aims to build distribution networks and joint product development for the Chinese and broader Asian markets.
- Beautyplus Holdings Hongkong LimitedmoderateBusiness and capital partnership established in May 2015 for building cooperative relationships for cosmetics sales in the Chinese market. Formed as part of the company's international expansion strategy for cosmetics.
- Professor Kondo Katsuya (東京慈恵会医科大学 近藤一博教授)coreJoint venture established with Professor Kondo of The Jikei University School of Medicine, co-founding Virus Medical Science Research Institute (株式会社ウイルス医科学研究所). The company conducts R&D on fatigue quantification technology and gene therapy vectors using the professor's human herpes virus research成果.
- Elc Corporation (株式会社エルクコーポレーション)moderateLicensing partner for ATMT technology. Elc Corporation commercialized the ATMT as a 'Brain Age Meter ATMT' product, providing reach to consumer health device market.
- 一般社団法人専門医ヘルスケアネットワーク (Medical Specialist Healthcare Network)minorA general incorporated association partner for healthcare network development, linked in the footer as a partner organization.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Soiken competitors and assessment
Company assessmentBroad incumbents
- Yakult Honsha: Japanese functional food and beverage company with probiotic and health-positioned consumer products. Comparable in functional food positioning and DTC retail distribution in Japan to Soiken's Imidapeptide brand.
- Fancl Corporation: Japanese health and cosmetics company focused on supplements and skincare, with direct-to-consumer e-commerce and drugstore distribution. Comparable channel strategy and supplement customer base to Soiken's Imidapeptide business.
- Morinaga Milk Industry: Japanese dairy and functional ingredients company with lactoferrin-related products and functional food lines. Direct adjacency to Soiken's lactoferrin development at NRL Pharma, overlapping in functional ingredient IP and Japanese health food channels.
- Kobayashi Pharmaceutical: Major Japanese OTC pharmaceutical and household products company with strong drugstore channel presence. Competes with Soiken in Japanese drugstore retail distribution of health supplements and self-medication products.
- H.U. Group Holdings (formerly SRL/Hitachi): Japanese clinical laboratory and healthcare services conglomerate. Comparable in clinical testing, biomarker services, and healthcare support offerings to Soiken Institute's evaluation testing and healthcare support divisions.
- Otsuka Holdings: Diversified Japanese healthcare company with significant pharmaceutical, nutraceutical, and consumer health product portfolios. Comparable to Soiken in the Japanese consumer health and functional food segments, though at vastly larger scale.
- Taisho Pharmaceutical Holdings: Large Japanese OTC and supplement company with significant self-medication and consumer health products business. Broad incumbent in the same Japanese supplement and self-medication space as Soiken's Imidapeptide brand, with far larger distribution and marketing scale.
Direct peers
- EPS Holdings: Japanese CRO and healthcare solutions provider offering clinical trial support, site management, and SMO services. Comparable to Soiken's clinical evaluation testing and healthcare support offerings to enterprise customers.
- CMIC Holdings: Japanese Contract Research Organization (CRO) providing clinical development, clinical trial services, and healthcare support. Most directly comparable to Soiken Institute's evaluation testing services and B2B healthcare support business, serving overlapping food/pharmaceutical enterprise customers.
Regional players
- SRL (subsidiary of H.U. Group Holdings): Japanese clinical testing laboratory offering biomarker and diagnostic testing services to medical institutions. Comparable to Soiken Institute's clinical evaluation testing business with overlapping biomarker/diagnostic testing methodologies and food/pharma enterprise customers.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Soiken social profiles
Digital presenceSoiken financial estimates
Financial estimateRevenue estimate
Valuation estimate
Soiken leadership team
Management profileNumber of profiles
Profiles9 records
Soiken subsidiaries and ownership
Company hierarchySubsidiaries6 records
Soiken funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Soiken M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Soiken
What does Soiken do?
Soiken Holdings is a Japanese healthcare holding company that commercializes university-derived biomarker and biological evaluation technologies. It sells contracted clinical evaluation testing for foods and pharmaceuticals, develops and licenses biomarker technologies (ATMT for mental fatigue/dementia, HHV-6/HHV-7 fatigue quantification), produces the Imidapeptide-based anti-fatigue health supplement line, and delivers preventive healthcare support services to health insurance associations.
Is Soiken a public or private company?
Soiken is a public company. It is classified as public and is currently operating.
When was Soiken founded?
Soiken was founded in 1994. It employs 51 to 100 people.
Where is Soiken based?
Soiken is headquartered in Toyonaka, Japan, in the Asia region.
How does Soiken make money?
Six revenue lines are on record. Evaluation Testing Services (評価試験事業) is the primary driver. The others are biomarker Development (バイオマーカー開発事業), health Supplement Business (健康補助食品事業), cosmetics Business (化妆品事業), healthcare Support Services (ヘルスケアサポート事業) and functional Ingredients Development (功能性素材開発事業).
Who are Soiken's main competitors?
Broad incumbents on record are Yakult Honsha, Fancl Corporation, Morinaga Milk Industry, Kobayashi Pharmaceutical, H.U. Group Holdings (formerly SRL/Hitachi), Otsuka Holdings and Taisho Pharmaceutical Holdings. Direct peers are EPS Holdings and CMIC Holdings. SRL (subsidiary of H.U. Group Holdings) is listed as a regional player.
Does Soiken have an API?
No public API is recorded for Soiken.
What industry is Soiken in?
Soiken's product category is Biomarker-based Healthcare & Contract Research. Its primary akta.pro industry code is HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints, with a secondary code of AFALAAAO, Risk Assessment, Hazard Analysis & Food Defense/Fraud Programs. Its NAICS code is 541380 and its SIC code is 8734.